ArticleGynecologic oncology reports2025

First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage.

Rose Emlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.